Teva
TEVA
|
NYSE
|
16 Followers
Fair Price
$86.24
Overvalued by 80.2%
To display the fair price of a share, you need to be a member of Bulios Black.
Company Quality
Profitability Score
26/100
Solvency Score
31/100
Dividends
Dividends data currently unavailable.Earnings
7/30/2025
in 57 days
$4.4B
Revenue est.
0.67
EPS est.
My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sector
Drug Manufacturers - Specialty & Generic
Industry
Mr. Richard D. Francis
CEO
37000
Employees
Tel Aviv
Headquarters
IL
Country
The Farmeceutical Society. There in general I would say it's kind of, well, the rate of it if? ...even like others, if they can develop a drug or just whatever they can get to market, then it's great and it can definitely grow. I don't know the company, I'm talking in general now that I think companies like that always experience a boom when either there's a pandemic or they come out with a new drug.